Imperial College Innovations Ltd.

For Sir Richard Sykes, chairman of GlaxoSmithKline PLC and Rector of Imperial College of Science Technology & Medicine since the beginning of 2001, strong interaction between different faculties is the key to effectively exploiting the College's intellectual assets. The interdisciplinary approach taken by the College itself-its new BioMedical building built in the heart of the campus, close to Chemistry and Engineering-and by Imperial College Innovations Ltd., the College's technology transfer company, reflects this belief. "The Rector's view is that the big technologies of the future will be founded at the interstices of the various faculties," outlines Jon Taylor, former CEO of Imperial College Innovations.